Au procès de la fondatrice de Theranos, l'accusation plaide la fraude, la défense la bonne foi
2021-12-17
Orange Actualités

The information displayed in the AIM should not be reported as representing the official views of the OECD or of its member countries.
Elizabeth Holmes, founder of Theranos, is on trial in the United States for allegedly defrauding investors and endangering patients by promoting AI-based blood testing technology that failed to perform as claimed. The malfunction and misrepresentation of the AI system led to financial and health-related harm.[AI generated]